Previous Article | Next Article ![]()
Infection and Immunity, November 1998, p. 5301-5306, Vol. 66, No. 11
Microbiology Department, University of
Tennessee, Knoxville, Tennessee 379191 and
Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts
021392
Received 17 April 1998/Returned for modification 3 June
1998/Accepted 1 September 1998
The ura-blaster technique for the disruption of Candida
albicans genes has been employed in a number of studies to
identify possible genes encoding virulence factors of this fungal
pathogen. In this study, the URA3-encoded orotidine
5'-monophosphate (OMP) decarboxylase enzyme activities of C. albicans strains with ura-blaster-mediated genetic
disruptions were measured. All strains harboring genetic lesions via
the ura-blaster construct showed reduced OMP decarboxylase activities
compared to that of the wild type when assayed. The activity levels in
different gene disruptions varied, suggesting a positional effect on
the level of gene expression. Because the URA3 gene of
C. albicans has previously been identified as a virulence factor for this microorganism, our results suggest that decreased virulence observed in strains constructed with the ura-blaster cassette
cannot accurately be attributed, in all cases, to the targeted genetic
disruption. Although revised methods for validating a
URA3-disrupted gene as a target for antifungal drug
development could be devised, it is clearly desirable to replace
URA3 with a different selectable marker that does not
influence virulence.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Altered Expression of Selectable Marker URA3 in
Gene-Disrupted Candida albicans Strains Complicates
Interpretation of Virulence Studies
*
Corresponding author. Mailing address: Microbiology
Department, University of Tennessee, F339 Walters Life Sciences Bldg., Knoxville, TN 37996-0845. Phone: (423) 974-3006. Fax: (423) 974-4007. E-mail: jbecker{at}utk.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|